China trials mixing of COVID-19 vaccines from CanSinoBIO and Zhifei Longcom - DataChinese researchers are also running trials for two-dose-based vaccination of Ad5-nCoV, as well as an inhalation version of the vaccine.Mon Apr 19 2021
